UNRESECTABLE OR METASTATIC MELANOMA
Clinical trials for UNRESECTABLE OR METASTATIC MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE OR METASTATIC MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE OR METASTATIC MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Melanoma drug combo study halted before full results
Disease control TerminatedThis study tested a combination of two drugs, ipilimumab and epacadostat, in people with advanced melanoma that could not be removed by surgery or had spread. The goal was to see if adding epacadostat to standard treatment improved survival. However, the study was stopped early f…
Matched conditions: UNRESECTABLE OR METASTATIC MELANOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug combo study halted after just 3 patients
Disease control TerminatedThis study tested a new drug called CX-072 combined with other cancer treatments for adults with solid tumors or advanced melanoma. The goal was to see if the combination could shrink tumors. However, the study was stopped early and only 3 people took part, so we don't have enoug…
Matched conditions: UNRESECTABLE OR METASTATIC MELANOMA
Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC